What is Oscor?
Founded in 1982 and headquartered in Palm Harbor, Florida, Oscor specializes in the manufacturing and global marketing of critical medical devices, including cardiac pacemaker parts and catheters. The company has established a worldwide presence, serving the healthcare industry with its specialized product lines. Oscor's longevity in the market points to a consistent ability to adapt and innovate within the competitive medical device sector.
How much funding has Oscor raised?
Oscor has raised a total of $147M across 2 funding rounds:
Unspecified
$145M
Debt
$2M
Unspecified (2015): $145M, investors not publicly disclosed
Debt (2020): $2M led by PPP
Key Investors in Oscor
PPP
Public-Private Partnership
What's next for Oscor?
The recent major strategic investment, coupled with the substantial overall capital secured by Oscor, positions the company for accelerated expansion and technological advancement. This significant backing suggests a focus on scaling operations, enhancing product development, and potentially exploring new market opportunities. As a mature player in the medical device industry, Oscor is likely leveraging this financing to solidify its competitive edge and further its mission of providing essential cardiac care components globally.
See full Oscor company page
